Eraqi Mohamed, Ghazy Tamer, Cerqueira Tiago, Leip Jennifer Lynne, Siepmann Timo, Mahlmann Adrian
Department of Cardiac Surgery, Klinikum Bayreuth GmbH, Bayreuth, Germany.
Department of Cardiac Surgery, Heart Center Dresden, Carl Gustav Carus University Hospital, Dresden, Germany.
Thorac Cardiovasc Surg. 2025 Sep;73(6):456-467. doi: 10.1055/s-0044-1791947. Epub 2024 Nov 18.
Although advancements in the management of thoracic aortic disease have led to a reduction in acute mortality, individuals requiring postoperative reintervention experience substantially worse long-term clinical outcomes and increased mortality. We aimed to identify the risk factors for postoperative reintervention in this high-risk population.This prospective observational cohort study included patients who survived endovascular or open surgical treatment for thoracic aortic disease between January 2009 and June 2020. We excluded those with inflammatory or traumatic thoracic aortic diseases. The risk factors were identified using multivariate logistic regression and Cox proportional hazards regression models.The study included 95 genetically tested patients aged 54.13 ± 12.13 years, comprising 67 men (70.53%) and 28 women (29.47%). Primary open surgery was performed in 74.7% and endovascular repair in 25.3% of the patients. Of these, 35.8% required one or more reinterventions at the time of follow-up (3 ± 2.5 years, mean ± standard deviation). The reintervention rate was higher in the endovascular repair group than in the open repair group. Among the potential risk factors, only residual aortic dissection emerged as an independent predictor of reintervention (odds ratio: 3.29, 95% confidence interval: 1.25-8.64).Reintervention after primary thoracic aortic repair remains a significant clinical issue, even in high-volume tertiary centers. Close follow-up and personalized care at aortic centers are imperative. In our cohort of patients with thoracic aortic disease undergoing open or endovascular surgery, postoperative residual dissection was independently associated with the necessity of reintervention, emphasizing the importance of intensified clinical monitoring in these patients.
尽管胸主动脉疾病管理方面的进展已使急性死亡率有所降低,但需要术后再次干预的患者长期临床结局显著更差,死亡率也更高。我们旨在确定这一高危人群术后再次干预的危险因素。这项前瞻性观察性队列研究纳入了2009年1月至2020年6月期间因胸主动脉疾病接受血管内或开放手术治疗后存活的患者。我们排除了患有炎性或创伤性胸主动脉疾病的患者。使用多变量逻辑回归和Cox比例风险回归模型确定危险因素。该研究纳入了95例接受基因检测的患者,年龄为54.13±12.13岁,其中男性67例(70.53%),女性28例(29.47%)。74.7%的患者接受了初次开放手术,25.3%的患者接受了血管内修复。其中,35.8%的患者在随访时(3±2.5年,均值±标准差)需要进行一次或多次再次干预。血管内修复组的再次干预率高于开放修复组。在潜在危险因素中,只有残余主动脉夹层成为再次干预的独立预测因素(比值比:3.29,95%置信区间:1.25 - 8.64)。即使在大型三级中心,初次胸主动脉修复后的再次干预仍然是一个重大临床问题。主动脉中心进行密切随访和个性化护理至关重要。在我们这组接受开放或血管内手术的胸主动脉疾病患者中,术后残余夹层与再次干预的必要性独立相关,强调了对这些患者加强临床监测的重要性。